NASDAQ · Biotechnology

uniQure N.V. (QURE) Stock

$22.54 -2.59% NASDAQ: QURE Healthcare

Valuation

MetricValue
Price$22.54
Market Cap$1.56B
P/E Ratio-5.66
P/B Ratio4.68
P/S Ratio84.97
EPS (TTM)$-2.48
52-Week High$71.50
52-Week Low$8.73
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-111.96%
ROA-25.60%
ROCE-22.55%
Gross Margin74.14%
Operating Margin-10.57%
Net Margin-11.54%
Debt/Equity0.19
Current Ratio10.41

Annual Financials (USD)

Metric20212022202320242025
Revenue$524.0M$106.0M$16.0M$27.0M$16.0M
Operating Profit$311.0M$-143.0M$-283.0M$-184.0M$-188.0M
Net Profit$330.0M$-127.0M$-308.0M$-240.0M$-199.0M
EPS$7.04$-2.71$-6.47$-4.92$-3.46
Op Margin59.3%-134.4%-1785.5%-679.6%-1166.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$809.0M$705.0M$832.0M$557.0M$825.0M
Total Liabilities$213.0M$229.0M$624.0M$563.0M$626.0M
Cash$556.0M$228.0M$241.0M$159.0M$80.0M
Borrowings$136.0M$143.0M$138.0M$66.0M$537.0M

Latest News

Uniqure Insider Sold Shares Worth $952,051, According to a Recent SEC Filing MT Newswires · Jul 7, 2026 Uniqure Insider Sold Shares Worth $983,030, According to a Recent SEC Filing MT Newswires · Jul 2, 2026 uniQure (QURE) Now Trades Above Golden Cross: Time to Buy? Zacks · Jul 1, 2026 XBI Ignored The Market's Downturn Trefis · Jun 29, 2026 UniQure Closes $259 Million Stock Offering MT Newswires · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$288.0M$-145.0M$-146.0M$-183.0M$-178.0M
Investing Cash Flow$-85.0M$-200.0M$-213.0M$160.0M$-322.0M
Financing Cash Flow$-1.0M$0$-8.0M$-9.0M$23.0M
Net Cash Flow$312.0M$-328.0M$13.0M$-84.0M$-79.0M
Free Cash Flow$271.0M$-163.0M$-153.0M$-186.0M$-178.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.54
EV / EBITDA-6.83
FCF Yield-10.15%
Quick Ratio10.01
Interest Coverage-3.41
Return 1Y183.37%
Return 3Y302.99%
Return 5Y55.25%

Ownership

Insiders Held1.29%
Institutions Held90.20%
Institutions Float Held91.38%
Institutional HolderSharesReport Date
Avoro Capital Advisors LLC5,959,5952026-03-31
Aberdeen Group plc5,306,3862026-03-31
JPMORGAN CHASE & CO2,837,4662026-03-31
Two Sigma Investments, LP2,675,8712026-03-31
RTW Investments LP2,586,3562026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $333.27 -2.10% 38.93 $4.89T 0.32%
MSFTMicrosoft Corporation $527.93 +1.02% 28.68 $3.92T 0.76%
GOOGLAlphabet Inc. $352.52 +1.21% 16.94 $4.27T 0.26%
AMZNAmazon.com, Inc. $258.36 +1.69% 19.82 $2.78T 0.00%
METAMeta Platforms, Inc. $719.49 -0.19% 27.93 $1.83T 0.28%

About uniQure N.V.

uniQure N.V. is led by CEO Matthew Craig Kapusta, employs 209 people, headquartered in US, publicly traded since 2014.

uniQure N.V. (QURE) stock trades at $22.54 with a market capitalization of $1.56B. The stock is valued at a price-to-earnings (P/E) ratio of -5.66, price-to-book of 4.68, price-to-sales of 84.97. Over the past 52 weeks the stock has ranged between $8.73 and $71.50, and currently trades 68.5% below its 52-week high.

On profitability, uniQure N.V. generates a return on equity (ROE) of -111.96%, return on capital employed of -22.55%, an operating margin of -10.57%, a net profit margin of -11.54%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1167.49 -0.18% JNJ Johnson & Johnson $257.43 +0.37% ABBV AbbVie Inc. $274.33 +0.70% MRK Merck & Company, Inc. Common Stock (new) $143.09 +0.50% UNH UnitedHealth Group Incorporated Common Stock (DE) $383.12 +3.28% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $656.23 +0.65% AMGN Amgen Inc. $406.05 -0.34% GILD Gilead Sciences, Inc. $147.20 +0.07% ABT Abbott Laboratories $100.17 +1.71% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides